Eric Quéméneur

No open positions remaining

62 year

Health Technology

Consumer Services

Government

Profile

Eric Quéméneur is currently the Director & EVP-Research & Development at ElsaLys Biotech SAS. Prior to his current position, he served as the Deputy CEO and Director-Research & Development at Transgene SA from 2014 to 2024.
Before that, he was the Director-Research Programs at Comité de l’énergie Atomique from 2010 to 2014.
Dr. Quéméneur holds a doctorate degree from Université Claude Bernard Lyon 1 and an undergraduate degree from Institut National des Sciences Appliquées de Lyon, which he obtained in 1986.

Former positions of Eric Quéméneur

Companies	Position	End
TRANSGENE	Chief Tech/Sci/R&D Officer	09/09/2024
ELSALYS BIOTECH	Chief Tech/Sci/R&D Officer	-
Comité de l’énergie Atomique Comité de l’énergie Atomique General GovernmentGovernment Operates as agencies related to nuclear safety activities	Corporate Officer/Principal	31/08/2014

See the detail of Eric Quéméneur's experience

Training of Eric Quéméneur

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Eric Quéméneur's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Transgene SA Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer	Health Technology
Université Claude Bernard Lyon 1 Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Institut National des Sciences Appliquées de Lyon Institut National des Sciences Appliquées de Lyon Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Comité de l’énergie Atomique Comité de l’énergie Atomique General GovernmentGovernment Operates as agencies related to nuclear safety activities	Government
ElsaLys Biotech SAS ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology Designs, develops and supplies antibodies to modulate the immune system of patients	Health Technology